Shareholding disclosure

Roche Holding AG

Declared position

4.98%

Threshold

Crossed upwards

Timeline

Published

16.06.2012

Transaction

08.06.2012

Voting rights breakdown

Voting rights acquired4.98%

Voting rights sold0%

Below threshold0%

Notice details

CategoryGroup of shareholders

ExchangeXSWX

Notification ID

TBC6E00024

Beneficial owner

Roche Holding AG

Declared address

Roche Holding AG, 4070 Basel

Tochtergesellschaft des wirtschaftlich Berechtigten

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Roche Holding AG

Basilea Pharmaceutica AG, Allschwil16.06.2012TBC6E00024

Disclosure summary

Roche Holding AG disclosed a holding in Basilea Pharmaceutica AG, Allschwil on the acquisition side, published by SIX Exchange Regulation on 16.06.2012, at 4.98% of voting rights. Notice category: Group of shareholders.

Disclosed position

4.98%

Voting rights acquired

Voting rights acquired4.98%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Roche Holding AG disclosed a holding in Basilea Pharmaceutica AG, Allschwil, published on 16.06.2012.

Publication date16.06.2012

Transaction date08.06.2012

Issuing companyBasilea Pharmaceutica AG, Allschwil

Beneficial ownerRoche Holding AG

Declared addressRoche Holding AG, 4070 Basel

CategoryGroup of shareholders

Voting rights acquired4.98%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTBC6E00024

Commercial register

CHE-101.602.521

Registered

Zefix record

Conditions

Tochtergesellschaft des wirtschaftlich Berechtigten

Source: SIX Exchange Regulation · Publication date: 16.06.2012

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open